Trading Signals: SGEN Stock Price Prediction and Forecast (Fri. May. 30, 2003 - Wed. Dec. 13, 2023)(Seattle Genetics, Inc.)
| SGEN latest price $47.6500 (-0.36%) ($47.4000 - $48.6700) on Sat. Jul. 4, 2015. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.17% (three month average) | RSI | 56 | Latest Price | $47.6500(-0.36%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | SGEN advances 0.4% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support SGEN advance at 0% a week (0% probability) (0%) (0%) (0%) (0%) (0%) | Factors Impacting SGEN price | SGEN will decline at least -1.085% in a week (0% probabilities). (0%) (0%) (0%) (0%) (0%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.085% (StdDev 2.17%) | Hourly BBV | 0 () | Intraday Trend | -0.7% | | | |
|
5 Day Moving Average | $47.64(0.02%) | 10 Day Moving Average | $48.07(-0.87%) | 20 Day Moving Average | $47.58(0.15%) | To recent high | -4% | To recent low | 40% | Market Cap | $N/A | | | | Seattle Genetics, Inc. is a biotechnology company, which engages in the development and commercialization of antibody-based therapies for the treatment of cancer. Its products include Adcetris and Padcev. The firm is also advancing a pipeline of novel therapies for solid tumors and blood-related cancers. The company was founded by Clay B. Siegall and H. Perry Fell on July 15, 1997 and is headquartered in Bothell, WA. |